Login to Your Account

Cash-Rich NicOx Surges on $31M Altacor Acquisition Deal

By Cormac Sheridan
Staff Writer

Thursday, March 22, 2012
Shares in NicOx SA surged almost 35 percent Wednesday on news that the company had taken its first concrete step toward becoming a late-stage development and commercial player in opthalmology by entering a cash-and-shares acquisition agreement with Altacor Ltd. that could be worth as much as £19.5 million (US$30.9 million).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription